Home › Opioid Overdose › NCT07421102
Pilot of Mailing Buprenorphine
A Pragmatic Remote Approach to Improve Transitions of Care and Retention in Opioid Use Disorder Treatment
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age ≥ 18 * English-speaking * Diagnosed with OUD and initiated on buprenorphine during hospitalization * Discharging to a South Carolina address with a stable mailbox * Access to phone or computer Exclusion Criteria: * Active psychosis or suicidal ideation * Severe medical or neurocognitive impairment * Pending incarceration
About the study
This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.
What is being tested
- strategy of mailing buprenorphine (other)
Sponsor: Medical University of South Carolina · Participants: 20 · Started: Apr 8, 2026
Contact the study team
Official record on ClinicalTrials.gov — NCT07421102
Locations in the U.S.
| South Carolina | Medical University of South Carolina, Charleston (Not yet recruiting) Medical University of South Carolina, Charleston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.